Cat.#: ASSD-147
Description | Rhodamine phalloidin-TRITC is a red-orange fluorescent cytoskeleton stain that binds and labels F-actin. |
Size | 300 tests, 100μg |
Applications | Used for tissue sections, cell cultures, and cell-free experiments samples. |
Chemical Name | 7-[(4R)-5-[[[[4-[3,6-Bis(dimethylamino)xanthylium-9-yl]-3-carboxyphenyl]amino]thioxomethyl]amino]-4-hydroxy-L-leucine]phalloidin |
Molecule Weight | 1231.4 |
Molecular formula | C60H70N12O13S2 |
CAS Number | 1926163-50-9 |
PubChem identifier | 137247539 |
Purity | >95% |
Solubility | Soluble in DMSO |
Excitation | ~540 nm |
Emission | 565 nm |
Storage | Store at -20° C |
Shipping | Shipped at 4°C |
Important | For our 300 tests pack, you should dissolve the compound in 1.5 mL of methanol or DMSO to make a stock solution. The product may appear colorless in very dry solvent. |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ASSD-225 | Antifade Fluorescence Mounting Medium with Propidium Iodide (aqueous) (AC225) | 10 mL | inquiry |
ASSD-134 | FITC Phalloidin (AC134) | 300 tests, 100μg | inquiry |
ASSD-194 | 7-(Diethylamino)coumarin-3-carboxylic acid (AC194) | 100 mg | inquiry |
ASSD-210 | 7-Amino-4-methyl-3-coumarinacetic acid N-succinimidyl ester (AC210) | 5 mg | inquiry |
ASSD-192 | 4-Fluoro-7-nitrobenzofurazan (AC192) | 5 mg, 25 mg, 50 mg | inquiry |
ASSD-132 | Congo Red (AC132) | 100 mg, 1g | inquiry |
ASSD-155 | Bromophenol blue (AC155) | 5g | inquiry |
ASSD-180 | Ru(bpy)2(mcbpy-O-Su-ester)(PF6)2 (AC180) | 1 mg | inquiry |
ASSD-212 | 5(6)-Carboxy-2′,7′-dichlorofluorescein diacetate N-succinimidyl ester (AC212) | 25 mg | inquiry |
ASSD-204 | 7-Diethylamino-3-[N-(2-maleimidoethyl)carbamoyl]coumarin (AC204) | 1 mg, 5 mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.